Half-year report · Q2

Period2024-01-21 → 2024-07-20
Filed2024-09-03
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥117.6bn2024-01-21 → 2024-07-20Cons.Net sales
Revenue¥213.4bn2023-01-21 → 2024-01-20Cons.Net sales (5-year summary)
Revenue¥101.7bn2023-01-21 → 2023-07-20Cons.Net sales
Operating income¥2.3bn2024-01-21 → 2024-07-20Cons.Operating income
Operating income¥2.5bn2023-01-21 → 2023-07-20Cons.Operating income
Ordinary income¥1.4bn2024-01-21 → 2024-07-20Cons.Ordinary income
Ordinary income¥3.1bn2023-01-21 → 2024-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2023-01-21 → 2023-07-20Cons.Ordinary income
Profit before tax¥6.5bn2024-01-21 → 2024-07-20Cons.Income before income taxes
Profit before tax¥4.1bn2023-01-21 → 2023-07-20Cons.Income before income taxes
Net income (owners)¥4.9bn2024-01-21 → 2024-07-20Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.4bn2023-01-21 → 2024-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.3bn2023-01-21 → 2023-07-20Cons.Profit loss attributable to owners of parent
Net income¥4.7bn2024-01-21 → 2024-07-20Cons.Profit loss
Net income¥2.4bn2023-01-21 → 2023-07-20Cons.Profit loss
Total assets¥199.3bnat 2024-07-20Cons.Assets
Total assets¥177.6bnat 2024-01-20Cons.Assets
Total assets¥182.1bnat 2023-07-20Cons.Total assets (5-year summary)
Total liabilities¥105.2bnat 2024-07-20Cons.Liabilities
Total liabilities¥86.1bnat 2024-01-20Cons.Liabilities
Net assets / equity¥94.2bnat 2024-07-20Cons.Net assets
Net assets / equity¥91.5bnat 2024-01-20Cons.Net assets
Net assets / equity¥87.8bnat 2023-07-20Cons.Net assets (5-year summary)
Cash and deposits¥36.5bnat 2024-07-20Cons.Cash and deposits
Cash and deposits¥32.4bnat 2024-01-20Cons.Cash and deposits
Cash & equivalents¥36.3bnat 2024-07-20Cons.Cash and cash equivalents
Cash & equivalents¥33.7bnat 2024-01-20Cons.Cash and cash equivalents
Cash & equivalents¥33.0bnat 2023-07-20Cons.Cash and cash equivalents
Cash & equivalents¥29.2bnat 2023-01-20dCons.Cash and cash equivalents
Operating cash flow¥5.5bn2024-01-21 → 2024-07-20Cons.Net cash provided by used in operating activities
Operating cash flow¥9.2bn2023-01-21 → 2024-01-20Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.7bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.1bn2024-01-21 → 2024-07-20Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.2bn2023-01-21 → 2024-01-20Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.4bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in investment activities
Financing cash flow¥1.8bn2024-01-21 → 2024-07-20Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.2bn2023-01-21 → 2024-01-20Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥50m2023-01-21 → 2023-07-20Cons.Net cash provided by used in financing activities
EPS (basic)¥155.72024-01-21 → 2024-07-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥140.772023-01-21 → 2024-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥74.642023-01-21 → 2023-07-20Cons.Basic earnings loss per share (5-year summary)
Equity ratio46.4%at 2024-07-20Cons.Equity to asset ratio (5-year summary)
Equity ratio50.4%at 2024-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio47.2%at 2023-07-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-01-21 → 2024-07-20−¥167m
Reconciling Itemsreconcilingrevenue intersegment2024-01-21 → 2024-07-20−¥167m
Reconciling Itemsreconcilingsegment profit2024-01-21 → 2024-07-20−¥674m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2024-01-21 → 2024-07-20¥73.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2024-01-21 → 2024-07-20¥73.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2024-01-21 → 2024-07-20¥17m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2024-01-21 → 2024-07-20−¥238m
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2024-01-21 → 2024-07-20−¥295m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2024-01-21 → 2024-07-20¥11.1bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2024-01-21 → 2024-07-20¥11.1bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2024-01-21 → 2024-07-20¥3m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2024-01-21 → 2024-07-20¥899m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2024-01-21 → 2024-07-20¥26.8bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2024-01-21 → 2024-07-20¥26.8bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2024-01-21 → 2024-07-20¥2.3bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2024-01-21 → 2024-07-20¥6.9bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2024-01-21 → 2024-07-20¥6.7bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2024-01-21 → 2024-07-20¥146m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2024-01-21 → 2024-07-20¥324m
—segment totalrevenue2024-01-21 → 2024-07-20¥117.7bn
—segment totalrevenue external2024-01-21 → 2024-07-20¥117.6bn
—segment totalrevenue intersegment2024-01-21 → 2024-07-20¥167m
—segment totalsegment profit2024-01-21 → 2024-07-20¥3.0bn
Reconciling Itemsreconcilingrevenue2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingrevenue intersegment2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingsegment profit2023-01-21 → 2023-07-20−¥502m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥74.3bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥74.2bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥19m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥1.8bn
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2023-01-21 → 2023-07-20−¥296m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥3m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥776m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥462m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥6.4bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥6.2bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥180m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥239m
—segment totalrevenue2023-01-21 → 2023-07-20¥102.0bn
—segment totalrevenue external2023-01-21 → 2023-07-20¥101.7bn
—segment totalrevenue intersegment2023-01-21 → 2023-07-20¥204m
—segment totalsegment profit2023-01-21 → 2023-07-20¥3.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 557
ItemContextValueUnit
Decrease increase in inventories ope cfCurrentYTDDuration-1695000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration8027000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration8663000000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration69000000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration2463000000JPY
Decrease increase in other assets ope cfPrior1YTDDuration-471000000JPY
Decrease increase in other assets ope cfCurrentYTDDuration-481000000JPY
Increase decrease in other liabilities ope cfPrior1YTDDuration761000000JPY
Increase decrease in other liabilities ope cfCurrentYTDDuration644000000JPY
Subtotal ope cfPrior1YTDDuration3517000000JPY
Subtotal ope cfCurrentYTDDuration7720000000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration161000000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration346000000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-217000000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-575000000JPY
Income taxes paid ope cfPrior1YTDDuration-775000000JPY
Income taxes paid ope cfCurrentYTDDuration-1990000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration2685000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration5500000000JPY
Payments into time deposits inv cfPrior1YTDDuration-1999000000JPY
Payments into time deposits inv cfCurrentYTDDuration-3161000000JPY
Proceeds from withdrawal of time deposits inv cfPrior1YTDDuration3547000000JPY
Proceeds from withdrawal of time deposits inv cfCurrentYTDDuration2089000000JPY
Purchase of short term investment securities inv cfPrior1YTDDuration-6200000000JPY
Purchase of short term investment securities inv cfCurrentYTDDuration-5200000000JPY
Proceeds from sales and redemption of securities inv cfPrior1YTDDuration6400000000JPY
Proceeds from sales and redemption of securities inv cfCurrentYTDDuration5500000000JPY
Purchase of property plant and equipment and intangible assets inv cfPrior1YTDDuration-5841000000JPY
Purchase of property plant and equipment and intangible assets inv cfCurrentYTDDuration-3604000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YTDDuration58000000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration48000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-305000000JPY
Purchase of investment securities inv cfCurrentYTDDuration-512000000JPY
Proceeds from sales and redemption of investment securities inv cfPrior1YTDDuration2901000000JPY
Proceeds from sales and redemption of investment securities inv cfCurrentYTDDuration7403000000JPY
Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration-JPY
Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration-6642000000JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration1949000000JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration-JPY
Insurance proceeds inv cfPrior1YTDDuration864000000JPY
Insurance proceeds inv cfCurrentYTDDuration-JPY
Other net inv cfPrior1YTDDuration-16000000JPY
Other net inv cfCurrentYTDDuration-41000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration1358000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-4120000000JPY
Increase in short term loans payable fin cfPrior1YTDDuration41000000JPY
Increase in short term loans payable fin cfCurrentYTDDuration-JPY
Decrease in short term loans payable fin cfPrior1YTDDuration-JPY
Decrease in short term loans payable fin cfCurrentYTDDuration-41000000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration3000000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-01-20pass rounding
balance sheet identityconsolidated 2024-07-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-01-20pass
statement vs summary · net assetsconsolidated 2024-07-20pass
statement vs summary · net income attributable to parentconsolidated 2023-01-21/2023-07-20pass
statement vs summary · net income attributable to parentconsolidated 2024-01-21/2024-07-20pass
statement vs summary · operating cash flowconsolidated 2023-01-21/2023-07-20pass
statement vs summary · operating cash flowconsolidated 2024-01-21/2024-07-20pass
statement vs summary · revenueconsolidated 2023-01-21/2023-07-20pass
statement vs summary · revenueconsolidated 2024-01-21/2024-07-20pass
statement vs summary · total assetsconsolidated 2024-01-20pass
statement vs summary · total assetsconsolidated 2024-07-20pass